Strategic Advisors for Hospital-Based Groups
Baldhead, LLC is not an IDR filing company. We help hospital-based physician groups select and oversee the right IDR partners, negotiate the PSA language that makes selective strategies possible, educate the hospital so the path is open, and turn arbitration outcomes into stronger in-network rates.
We help you open the conversation so the health system understands why selective strategies protect patients and coverage.
We help you evaluate, select, and monitor the right specialized IDR company for your group's volume and goals.
We use IDR results and performance data to drive more favorable in-network rates in the next cycle.
Our Distinct Role
Baldhead is not an Independent Dispute Resolution company. We do not file claims or compete with the specialized platforms that do. Our job is to help hospital-based physician groups make the strategic decisions that make those platforms effective: secure the PSA flexibility, educate the hospital, choose the right partner, monitor performance, and convert outcomes into better contracted rates.
Most exclusive PSAs still lock groups into every hospital payer contract. We help design and negotiate language that allows carrier-by-carrier decisions while preserving exclusivity and coverage guarantees the hospital needs.
Health systems need to understand that patient hold-harmless remains absolute and that a selective strategy can strengthen, not threaten, coverage and recruitment. We prepare the materials and support the dialogue.
Once the path is open, one specialized company will need to be selected. We help evaluate options, set expectations, and then monitor performance so the group stays in control of results and economics.
What We Deliver
We stay focused on the decisions that pure IDR platforms cannot make for you: the relationship with the hospital, the terms of the PSA, which partner to choose, and how to turn wins into lasting rate improvements.
Map current exclusivity, network-participation, and termination language. Design practical amendments that open selective options while protecting the hospital's coverage and operational needs.
Prepare clear, non-adversarial materials that explain patient protections, cash-flow realities, and why a controlled strategy can support recruitment and service-line stability.
Help the group compare specialized partners on win rates, specialty focus, fee structure, reporting, technology, and cultural fit. Support the RFP or selection conversation.
Once a company is selected, help the group track eligibility discipline, offer quality, award rates, payment realization, and administrative burden so performance stays transparent.
Segment the book by funding type (DMHC vs. ERISA), benchmark rates, and identify which carriers are the highest-value targets for either improved contracts or selective pressure.
Use documented IDR outcomes and payer behavior to re-open rate negotiations and move high-performing relationships back into stronger, more sustainable in-network agreements.
Hospital Partnership
Without hospital alignment, selective strategies remain theoretical. We treat the health system as a partner whose coverage, recruitment, and patient-experience interests must be protected and advanced.
Still the dominant model. Opportunity: negotiate carrier-by-carrier flexibility language without giving up exclusivity or coverage commitments the hospital requires.
Blended economics give both sides more room to share risk and reward. Strong platform for joint strategy discussions about payer performance.
Shared operational accountability creates natural forums for reviewing payer scorecards and deciding when selective pressure is warranted.
Outpatient imaging or service-line JVs can diversify economics and strengthen the overall partnership while selective strategies are evaluated.
Why the Window Is Open
Sources: CMS Federal IDR Public Use Files and supplemental reports, 2023–2026; Health Affairs; Brookings; Radiology Business. Outcomes vary. Past public data do not guarantee future results for any specific group or vendor.
News & Insights
Curated public reporting and data that support the case for disciplined, patient-protected leverage — and for converting outcomes into better contracts.
Health Affairs analysis of CMS data shows providers and facilities initiated nearly all disputes and prevailed in 88% of determinations. Radiology Partners win rates reached 92–95% in the same period, with median awards several times the QPA.
Read the analysis →ACR, ASA and ACEP jointly welcomed the final rule as a "thoughtful and collaborative approach." Key wins for imaging groups: administrative fee cut to $15, expanded batching, and clearer eligibility transparency from payers.
Read the joint statement →Analysis of CMS data highlighted strong radiology performance in the federal IDR process, with median prevailing offers for radiology services reaching approximately six times the qualifying payment amount in the first half of 2024.
Read the report →The College highlighted expanded dispute bundling, the reduced administrative fee, and requirements that insurers provide necessary information with initial payments — changes that address long-standing barriers for radiology groups.
ACR summary →Physician groups continue to report that some insurers delay or ignore payment after losing determinations. Bipartisan legislation would strengthen enforcement and fines for missed 30-day payment deadlines.
Read the advocacy update →Legal analysis notes the final rule makes the process more accessible and workable — lower fees, better batching flexibility for radiology and related specialties, clearer timelines, and stronger transparency requirements.
Read the analysis →Links are to public third-party sources. We share them because they illustrate the regulatory and data environment our clients navigate. Inclusion does not imply endorsement of any IDR vendor or guarantee of similar outcomes for any group.
How Engagement Works
Review current PSA language, payer mix, hospital relationship dynamics, and any existing IDR activity. Identify the practical constraints and the highest-value opportunities.
Prepare education materials and proposed language concepts. Support the conversation with health-system leadership so the group gains the contractual flexibility needed.
Evaluate specialized companies against the group's volume, specialty mix, reporting needs, and economics. Help structure the relationship and success metrics.
Track partner performance. Use documented outcomes and payer behavior to reopen rate discussions and move relationships back into stronger in-network agreements where the numbers support it.
Why Groups Work With Us
We do not file IDR claims or earn a percentage of awards. Our incentives are aligned with the group's long-term contracting and hospital relationship goals.
We design strategies that can be explained to, and supported by, the health system. Coverage continuity and patient experience remain non-negotiable.
We help you select and then monitor the specialized company so you retain control of performance, reporting, and the decision to stay or switch.
Arbitration is a tool, not the destination. We keep the focus on converting leverage into sustainable in-network rates wherever possible.
Next Step
A confidential conversation about your current PSA, hospital dynamics, and whether a selective strategy is realistic for your group.